Go back

Gavi greenlights $1bn African vaccine manufacturing fund

                             

Initiative a “game-changer” for continent’s plan to produce own jabs

The Global Vaccine Alliance has approved a financing mechanism to support Africa’s efforts to build a sustainable vaccine manufacturing industry.

The African Vaccine Manufacturing Accelerator was approved by the Gavi board on 7 December at a meeting in Accra, Ghana. It will aim to pump US$1 billion into Africa’s vaccine manufacturing industry over the next 10 years, to help the continent meet its aim of locally producing 60 per cent of its routine immunisations by 2040.

This article on Research Professional News is only available to Research Professional or Pivot-RP users.

Research Professional users can log in and view the article via this link

Pivot-RP users can log in and view the article via this link.